AI-curated court updates, legal developments, and practice-area insights for Indian legal professionals.
The ROC Cuttack has imposed penalties due to a four-year delay in filing Form CSR-2 for FY 2020-21, totaling ₹2 lakh on the company and ₹50,000 each on two officers.
The Registrar of Companies (ROC) Kolkata has imposed penalties for incorrect MGT-7 filings on a company and its certifying director, totaling ₹10,000.
The NCLT ruled that employees of Jet Lite cannot be recognized as workmen of Jet Airways during liquidation due to their payroll status.
The ROC Kolkata has issued penalties against a company and its director for incorrect filing of AOC-4, reflecting stricter regulatory oversight in corporate disclosures.
The Registrar of Companies in Kolkata has imposed penalties on a company and its certifying director for incorrect MGT-7 filings, reinforcing compliance under Rule 8(3) and Section 450.
The CDSCO's recent notice invites comments on brand name extensions in pharmaceuticals, highlighting an ongoing regulatory concern.
The RBI has modified reporting requirements under FEMA, improving clarity and compliance for authorized persons involved in foreign exchange transactions.
SEBI's guide clarifies the eligibility criteria, NISM certification requirements, and compliance documents needed for individuals aspiring to register as Investment Advisers in India.
SEBI's recent notification establishes a requirement for custodians to report and remit fees on a monthly basis, effective October 1, 2026. This change is aimed at ensuring timely oversight of custodian activities.
DPIIT has extended the deadline for legacy stock clearance in footwear and allowed imports for R&D purposes, indicating support for the industry.
On July 14, 2026, holders of the Sovereign Gold Bond 2020-21 Series-IV can redeem their bonds prematurely as permitted by government notification. The redemption price will be based on average closing rates of gold.
The Directorate General of Health Services has invited comments on the use of brand name extensions in pharma, potentially signaling regulatory changes that could affect marketing strategies of pharmaceutical companies.
The RBI has outlined key information regarding the Annual Return on Foreign Liabilities and Assets (FLA) reporting, including the July 15 deadline and filing requirements under FEMA.